Edith Mitchell, MD, MACP, FCCP, FRCP

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Employment
    Ineligible company:
    Thomas Jefferson University
    Date added:
    04/19/2023
    Date updated:
    04/19/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Bristol, Myers, Squibb
    Topic:
    Consultant
    Date added:
    04/19/2023
    Date updated:
    04/19/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Amgen
    Topic:
    Consultant
    Date added:
    04/19/2023
    Date updated:
    04/19/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    SEMA4
    Topic:
    Consultant
    Date added:
    04/19/2023
    Date updated:
    04/19/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Astellas
    Topic:
    Consultant
    Date added:
    04/19/2023
    Date updated:
    04/19/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Corvus
    Topic:
    Board Member
    Date added:
    04/19/2023
    Date updated:
    04/19/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Genentech
    Topic:
    Consultant
    Date added:
    04/19/2023
    Date updated:
    04/19/2023
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Genentech
    Topic:
    Research funding to institution
    Date added:
    04/19/2023
    Date updated:
    04/19/2023
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Sanofi
    Topic:
    Research funding to institution
    Date added:
    04/19/2023
    Date updated:
    04/19/2023
Return to 2023 Summit on Cancer Health Disparities: Reframing and Addressing Barriers to Adoption of Precision Oncology